Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke

J Infect Dis. 2012 Feb 15;205(4):535-9. doi: 10.1093/infdis/jir788. Epub 2012 Jan 5.

Abstract

Concerns have arisen about possible effects of protease inhibitors (PIs) on cardiac conductivity. We found no significant association between current or recent PI exposure and sudden death or nonhemorrhagic stroke (adjusted rate ratio, 1.22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11).

MeSH terms

  • Adult
  • Death, Sudden / epidemiology*
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Risk Assessment
  • Stroke / epidemiology*
  • Stroke / mortality*

Substances

  • HIV Protease Inhibitors